Recent studies have suggested that INSM1 has high diagnostic accuracy in identifying pulmonary neuroendocrine neoplasms, particularly SCLC and LCNEC, with reported sensitivity ranging from 68% to 95% and specificity from 95% to 99% [11,19]. This evidence concerns the gene INSM1 and lung neuroendocrine neoplasm.